Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 1191-1195, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van den Bergh, F. A.J.T.M.
Right arrow Articles by Bon, M. A.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van den Bergh, F. A.J.T.M.
Right arrow Articles by Bon, M. A.M.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Hemostasis and Thrombosis
(Clinical Chemistry. 2000;46:1191-1195.)
© 2000 American Association for Clinical Chemistry, Inc.


Technical Briefs

Rapid Single-Tube Genotyping of the Factor V Leiden and Prothrombin Mutations by Real-Time PCR Using Dual-Color Detection

Frank A.J.T.M. van den Bergha, Arletta M. van Oeveren-Dybicz1 and Michelle A.M. Bon1

1 Department of Clinical Chemistry, Medisch Spectrum Twente, Hospital Group, PO Box 50000, 7500 KA Enschede, The Netherlands
a author for correspondence: fax 31-53-487-3075, e-mail labmst@euronet.nl

Patients carrying the G1691A mutation in the factor V gene (factor V Leiden) have been demonstrated to be at risk for venous thromboembolism. A second polymorphism also associated with hereditary thrombophilia was identified in the prothrombin gene (G20210A). Because of the high prevalence of these two mutations (5–10% for G1691A and 2–4% for G20210A) in the Caucasian population, there is growing demand for rapid, reliable, and simple methods for combined detection of both point mutations. Numerous PCR-based assays have been described for the detection of each of the mutations separately (1)(2)(3)(4) as well as in combination by multiplex PCR analysis (5)(6)(7)(8)(9)(10) and other single-tube alternatives [see, for example, Ref. (11)]. All of these methods, however, are time-consuming and require multiple manual steps such as restriction length polymorphism analysis, electrophoresis, and hybridization with specific oligonucleotide probes.

Recently, a new detection methodology was introduced on high-speed thermal cyclers based on real-time PCR analysis followed by hybridization of amplicon-specific oligonucleotides with adjacent fluorophores capable of fluorescence resonance energy transfer (LightCyclerTM; Roche Molecular Biochemicals). Probes, labeled with two different fluorescent molecules, hybridize next to each other on the target DNA molecule. The first fluorescent dye, the donor dye fluorescein, is excited at 470 nm by the light source of the LightCycler. Instead of emitting light at 530 nm, the fluorescein can transfer its energy in a nonfluorescent manner to a reporter dye. The reporter dye emits light of a longer wavelength, e.g., 640 nm. This process, called fluorescence resonance energy transfer (FRET), enables real-time detection of the specific PCR product followed by melting curve analysis, which monitors the temperature-dependent hybridization with fluorescent oligonucleotide probes to single-stranded DNA. The success of this . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
A. Castley, M. Higgins, J. Ivey, C. Mamotte, D. C. Sayer, and F. T. Christiansen
Clinical Applications of Whole-Blood PCR with Real-Time Instrumentation
Clin. Chem., November 1, 2005; 51(11): 2025 - 2030.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Luderer, A. Verheul, and W. Kortlandt
Rapid Detection of the Factor V Leiden Mutation by Real-Time PCR with TaqMan Minor Groove Binder Probes
Clin. Chem., April 1, 2004; 50(4): 787 - 788.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. L. Smit, B. A.J. Giesendorf, J. A.M. Vet, F. J.M. Trijbels, and H. J. Blom
Semiautomated DNA Mutation Analysis Using a Robotic Workstation and Molecular Beacons
Clin. Chem., April 1, 2001; 47(4): 739 - 744.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.